EW has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
EW has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Edwards Lifesciences's Accounts Payable for the quarter that ended in Sep. 2024 was $173 Mil.
Edwards Lifesciences's quarterly Accounts Payable declined from Mar. 2024 ($212 Mil) to Jun. 2024 ($186 Mil) and declined from Jun. 2024 ($186 Mil) to Sep. 2024 ($173 Mil).
Edwards Lifesciences's annual Accounts Payable declined from Dec. 2021 ($205 Mil) to Dec. 2022 ($202 Mil) and declined from Dec. 2022 ($202 Mil) to Dec. 2023 ($201 Mil).
The historical data trend for Edwards Lifesciences's Accounts Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edwards Lifesciences Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Accounts Payable | Get a 7-Day Free Trial |
![]() |
![]() |
196.50 | 204.50 | 201.90 | 201.40 | - |
Edwards Lifesciences Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Accounts Payable | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
201.40 | 212.30 | 185.90 | 172.80 | - |
Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.
Thank you for viewing the detailed overview of Edwards Lifesciences's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.
Steven R Loranger | director | XYLEM. INC., 1133 WESTCHESTER AVENUE, WHITE PLAINS NY 10604 |
Heisz Leslie Stone | director | C/O PUBLIC STORAGE, 701 WESTERN AVENUE, GLENDALE CA 91201 |
Scott B. Ullem | officer: CVP, CFO | C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614 |
Bobo Donald E Jr | officer: CVP,Strategy/Corp Development | C/O EDWARDS LIFESCIENCES, ONE EDWARDS WAY, IRVINE CA 92614 |
Wayne Markowitz | officer: GM & SVP, Surgical | ONE EDWARDS WAY, IRVINE CA 92614 |
Daveen Chopra | officer: CVP, Surgical Structural Heart | C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92618 |
Larry L Wood | officer: CVP, THV Replacement | C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614 |
Bernard J Zovighian | officer: CVP, Surgical Heart Valves | C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614 |
Michael A Mussallem | director, officer: Chairman & CEO | C/O EDWARDS LIFESCIENCES CORP, ONE EDWARDS WAY, IRVINE CA 92614 |
Jean-luc M Lemercier | officer: CVP, EMEA, Canada, Latin Amer | C/O ONE EDWARDS WAY, IRVINE CA 92614 |
Kieran Gallahue | director | PO BOX 684369, PARK CITY UT 84068 |
Catherine M. Szyman | officer: CVP, Critical Care | C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614 |
Sellers Robert W.a. | officer: VP, Corp. Controller (Principa | ONE EDWARDS WAY, IRVINE CA 92614 |
Huimin Wang | officer: CVP, Japan & Intercontinental | C/O EDWARDS LIFESCIENCES, ONE EDWARDS WAY, IRVINE CA 92614 |
Martha H. Marsh | director | 9769 WEXFORD CIRCLE, GRANITE BAY CA 95746 |
From GuruFocus
By PRNewswire • 12-12-2024
By PRNewswire • 12-12-2024
By GuruFocus News • 01-30-2025
By PRNewswire • 12-12-2024
By Marketwired • 12-12-2024
By GuruFocus News • 02-14-2025
By Business Wire • 02-11-2025
By Marketwired • 12-13-2024
By GuruFocus News • 02-12-2025
By Business Wire • 02-04-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.